Essilor Supports IMI’s 2021 Series of White Papers on Myopia
The International Myopia Institute (IMI) recently released the 2021 edition of white papers in a special issue of the peer-reviewed Investigative Ophthalmology and Visual Science (IOVS) journal. The white papers are supported by IMI platinum sponsors, including Essilor and other leading industry players, and follow the first series published in 2019.
The new white papers have been authored by leading global experts in myopia, and cover key topics such as pathologic myopia, impact of myopia, risk factors for myopia, accommodation and binocular vision in myopia development and progression, and prevention of myopia and its progression.
As myopia research and interventions continue to advance, the new white papers will serve as an evidence-based guide to eye care practitioners globally on understanding the ‘who’, ‘when’ and ‘how’ of myopia management, along with the benefits and limitations of myopia management approaches.
Dr. Monica Jong, Executive Director of the IMI, said “The original IMI 2019 white papers helped change the way clinicians thought of myopia – as an ocular condition versus a purely refractive issue – the latest IMI 2021 white papers continue to build on the evidence-base for implementing myopia management. Collaboration between all eye care stakeholders is the key to advancing research, awareness and making clinical management affordable and accessible to all children with myopia.”
Olga Prenat, VP, Education and Professional Relations, Essilor International, said, “These evidence-based papers can positively impact how myopia is managed, helping us fulfil our goal of minimizing associated vision health risks in future generations.”
Essilor also pledged its support for the publication of International Myopia Institute’s landmark series of white papers in 2019 and is a co-author of one of the white papers titled, ‘Industry Guidelines and Ethical Considerations for Myopia Control’. Since then, Essilor has published several articles in partnership with IMI, to share expert insights on improving clinical myopia management and to offer a glimpse into IMI’s successful efforts and new developments.
Click HERE for the full press release.